v3.26.1
INTANGIBLE UNDER DEVELOPMENT (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
GNQ INSILICO INC [Member]    
Restructuring Cost and Reserve [Line Items]    
SCHEDULE OF INTANGIBLE ASSETS

The following table summarizes intangible assets:

 

   Drug
Assessment
Platform
   Bio Avatar
(formerly
Digital
Twins
Platform)
   Drug
Simulation
Platform
   Total 
Balance, January 1, 2025  $605,830   $14,806   $-   $620,636 
Additions: Capitalized costs   1,070,327    448,962    184,227    1,703,516 
Amortization   (69,553)   -         (69,553)
Balance, December 31, 2025  $1,606,604   $463,768   $184,227   $2,254,599 
Additions: Capitalized costs   150,056    186,401    27,000    363,457 
Amortization   (69,547)   -         (69,547)
Balance, March 31, 2026  $1,687,113   $650,169   $211,227   $2,548,509 

The following table summarizes intangible assets:

 

   Drug Assessment Platform   Digital Twins Platform   Drug Simulation Platform   Total 
Balance, January 1, 2024   -    -    -    - 
Additions: Capitalized costs  $605,830   $14,806    -   $620,636 
Amortization   -    -    -    - 
Balance, December 31, 2024   605,830    14,806    -    620,636 
Additions: Capitalized costs   1,070,327    448,962   $184,227    1,703,516 
Amortization   (69,553)   -         (69,553)
Balance, December 31, 2025  $1,606,604   $463,768   $184,227   $2,254,599